The Plan is administered by the Compensation Committee or such other Board committee (or the entire Board) as may be designated by the Board.


	Years Ended
	June 28, 2026		June 29, 2025		June 30, 2024

	(in thousands)

Stock options	$	2,634	$	4,729	$	4,422
Restricted stock awards	8,622		7,162		6,266
Total	11,256		11,891		10,688

(1)Stock-based compensation expense has not been allocated among business segments, but is reflected as part of Corporate overhead (See Note 17 - Business segments for details).


	Years Ended
	June 28, 2026		June 29, 2025		June 30, 2024

	(in thousands)

Marketing and sales	$	5,178	$	5,470	$	4,916
Technology and development	901		951		855
General and administrative	5,177		5,470		4,917
Total	$	11,256	$	11,891	$	10,688

The weighted average fair value of stock options on the date of grant, and the assumptions used to estimate the fair value of the stock options using the Black-Scholes option valuation model, were as follows:


	Years Ended
	June 28, 2026	June 29, 2025	June 30, 2024
	(1)
Weighted average fair value of options granted	n/a	$3.25	$6.09
Expected volatility	n/a	58%	56%
Expected life (in years)	n/a	7	7
Risk-free interest rate	n/a	4.3%	3.9%
Expected dividend yield	n/a	—%	—%

The expected volatility of the option is determined using historical volatilities based on historical stock prices. The Company estimated the expected life of options granted based upon the historical weighted average. The risk-free interest rate is determined using the yield available for zero-coupon U.S. government issues with a remaining term equal to the expected life of the option. The Company has never paid a dividend, and as such the dividend yield is 0.0%.


	Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
				(in years)	(in thousands)
Outstanding beginning of period	3,329,718	$	8.59
Granted	—	$	—
Exercised	—	$	—
Forfeited/Expired	(445,896)	$	8.59
Outstanding end of period	2,883,822	$	8.59	6.97	$	—

Exercisable at June 28, 2026	1,938,093	$	8.71	6.48	$	—

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of fiscal 2026 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on June 28, 2026. This amount changes based on the fair market value of the Company’s stock. The total intrinsic value of options exercised during the years ended June 28, 2026, June 29, 2025, and June 30, 2024, were $0.0 million, $0.0 million, and $0.1 million, respectively.

As of June 28, 2026, the total future compensation cost related to non-vested options not yet recognized in the statement of operations was $4.1 million and the weighted average period over which these awards are expected to be recognized was 2.6 years.

The Company grants shares of Common Stock to its employees that are subject to restrictions on transfer and risk of forfeiture until fulfillment of applicable service conditions and, in certain cases, holding periods (Restricted Stock).


	Shares	Weighted Average Grant Date Fair Value

Non-vested – beginning of period	2,110,656	$	9.98
Granted	4,420,017	$	4.70
Vested	(841,448)	$	7.75
Forfeited	(1,543,474)	$	5.88
Non-vested - end of period	4,145,751	$	6.33

The fair value of shares vested was $3.4 million, $5.0 million, and $4.2 million during fiscal 2026, 2025, and 2024, respectively. The fair value of non-vested shares is determined based on the closing stock price on the grant date. As of June 28, 2026, there was $16.8 million of total unrecognized compensation cost related to non-vested, restricted, stock-based compensation to be recognized over a weighted-average period of 1.9 years.